ICONIQ

Medici Brands closes $250 million Series B at $2.25 billion valuation

Greenoaks and Valor Equity Partners co-led the Series B for the David Protein parent, which is projecting more than $300 million in 2026 revenue as it expands into confectionery and new brands.